David Michael

David Michael is an investor and advisor with nearly 30 years of international business experience. He co-founded Anzu Partners and developed the firm’s focus on breakthrough technologies that shape and enable tomorrow’s industries. He has pioneered the financing and growth of several Anzu portfolio companies. These include the life sciences tools companies TeraPore Technologies (now also backed by RA Capital), Nanocellect Biomedical (now also backed by Warburg Pincus and Casdin Capital), Bioskryb Genomics, ImmunoScape (now also backed by Amgen), and Intervenn Biosciences (now also backed by Softbank). In other industries, Mr. Michael has also helped pioneer Anzu portfolio firms Niron Magnetics (now also backed by Samsung, GM, and Volvo), and OTI Lumionics (now also backed by LG Technology Ventures, Samsung, and others). Mr. Michael is the co-author of six articles in the Harvard Business Review, one MIT Sloan Management Review article, two business books, and has delivered a TED talk. Mr. Michael has an MBA from Stanford Business School, where he received the school’s highest honor, the Ernest Arbuckle Award. He earned his BA in Economics, magna cum laude, from Harvard University, and was a Rotary International Scholar at the Chinese University of Hong Kong.